{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:36:22Z","timestamp":1773297382763,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,2,19]],"date-time":"2018-02-19T00:00:00Z","timestamp":1518998400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s40618-017-0822-8","type":"journal-article","created":{"date-parts":[[2018,2,19]],"date-time":"2018-02-19T14:18:50Z","timestamp":1519049930000},"page":"959-968","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Baseline and changes in serum uric acid independently predict 11-year incidence of metabolic syndrome among community-dwelling women"],"prefix":"10.1007","volume":"41","author":[{"given":"R.","family":"Kawamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Ninomiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Kasai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Senzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Kusunoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Ohtsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Kumagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,19]]},"reference":[{"key":"822_CR1","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.2337\/diacare.26.11.3153","volume":"26","author":"C Lorenzo","year":"2003","unstructured":"Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM (2003) The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care 26:3153\u20133159","journal-title":"Diabetes Care"},{"key":"822_CR2","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2337\/diacare.28.2.385","volume":"28","author":"AM McNeill","year":"2005","unstructured":"McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE, Ballantyne CM, Heiss G (2005) The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 28:385\u2013390","journal-title":"Diabetes Care"},{"key":"822_CR3","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1539\/joh.47.126","volume":"47","author":"K Shiwaku","year":"2005","unstructured":"Shiwaku K, Nogi A, Kitajima K, Anuurad E, Enkhmaa B, Yamasaki M, Kim JM, Kim IS, Lee SK, Oyunsuren T, Yamane Y (2005) Prevalence of the metabolic syndrome using the modified ATP III definitions for workers in Japan, Korea and Mongolia. J Occup Health 47:126\u2013135","journal-title":"J Occup Health"},{"key":"822_CR4","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s40618-016-0470-4","volume":"39","author":"S Popa","year":"2016","unstructured":"Popa S, Mota M, Popa A, Mota E, Serafinceanu C, Guja C, Catrinoiu D, Hancu N, Lichiardopol R, Bala C, Popa A, Roman G, Radulian G, Timar R, Mihai B (2016) Prevalence of overweight\/obesity, abdominal obesity and metabolic syndrome and atypical cardiometabolic phenotypes in the adult Romanian population: PREDATORR study. J Endocrinol Invest 39:1045\u20131053. https:\/\/doi.org\/10.1007\/s40618-016-0470-4","journal-title":"J Endocrinol Invest"},{"key":"822_CR5","doi-asserted-by":"publisher","first-page":"605","DOI":"10.2169\/internalmedicine.45.1661","volume":"45","author":"R Kawamoto","year":"2006","unstructured":"Kawamoto R, Tomita H, Oka Y, Ohtsuka N (2006) Relationship between serum uric acid concentration, metabolic syndrome and carotid atherosclerosis. Intern Med 45:605\u2013614","journal-title":"Intern Med"},{"key":"822_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3961\/jpmph.2012.45.3.181","volume":"45","author":"JM Lee","year":"2012","unstructured":"Lee JM, Kim HC, Cho HM, Oh SM, Choi DP, Suh I (2012) Association between serum uric acid level and metabolic syndrome. J Prev Med Public Health 45:181\u2013187. https:\/\/doi.org\/10.3961\/jpmph.2012.45.3.181","journal-title":"J Prev Med Public Health"},{"key":"822_CR7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.5539\/gjhs.v5n1p155","volume":"5","author":"A Ziaee","year":"2012","unstructured":"Ziaee A, Esmailzadehha N, Ghorbani A, Asefzadeh S (2012) Association between uric acid and metabolic syndrome in Qazvin Metabolic Diseases Study (QMDS) Iran. Glob J Health Sci 5:155\u2013165. https:\/\/doi.org\/10.5539\/gjhs.v5n1p155","journal-title":"Glob J Health Sci"},{"key":"822_CR8","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.metabol.2008.01.030","volume":"57","author":"X Sui","year":"2008","unstructured":"Sui X, Church TS, Meriwether RA, Lobelo F, Blair SN (2008) Uric acid and the development of metabolic syndrome in women and men. Metabolism 57:845\u2013852. https:\/\/doi.org\/10.1016\/j.metabol.2008.01.030","journal-title":"Metabolism"},{"key":"822_CR9","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.atherosclerosis.2011.11.014","volume":"220","author":"T Yang","year":"2012","unstructured":"Yang T, Chu CH, Bai CH, You SL, Chou YC, Chou WY, Chien KL, Hwang LC, Su TC, Tseng CH, Sun CA (2012) Uric acid level as a risk marker for metabolic syndrome: a Chinese cohort study. Atherosclerosis 220:525\u2013531. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.11.014","journal-title":"Atherosclerosis"},{"key":"822_CR10","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s12020-012-9629-8","volume":"41","author":"JP Goncalves","year":"2012","unstructured":"Goncalves JP, Oliveira A, Severo M, Santos AC, Lopes C (2012) Cross-sectional and longitudinal associations between serum uric acid and metabolic syndrome. Endocrine 41:450\u2013457. https:\/\/doi.org\/10.1007\/s12020-012-9629-8","journal-title":"Endocrine"},{"key":"822_CR11","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3164\/jcbn.12-65","volume":"52","author":"ML Zhang","year":"2013","unstructured":"Zhang ML, Gao YX, Wang X, Chang H, Huang GW (2013) Serum uric acid and appropriate cutoff value for prediction of metabolic syndrome among Chinese adults. J Clin Biochem Nutr 52:38\u201342. https:\/\/doi.org\/10.3164\/jcbn.12-65","journal-title":"J Clin Biochem Nutr"},{"key":"822_CR12","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s00380-013-0386-2","volume":"29","author":"E Oda","year":"2014","unstructured":"Oda E (2014) Serum uric acid is an independent predictor of metabolic syndrome in a Japanese health screening population. Heart Vessels 29:496\u2013503. https:\/\/doi.org\/10.1007\/s00380-013-0386-2","journal-title":"Heart Vessels"},{"key":"822_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.numecd.2015.10.007","volume":"26","author":"A Zurlo","year":"2016","unstructured":"Zurlo A, Veronese N, Giantin V, Maselli M, Zambon S, Maggi S, Musacchio E, Toffanello ED, Sartori L, Perissinotto E, Crepaldi G, Manzato E, Sergi G (2016) High serum uric acid levels increase the risk of metabolic syndrome in elderly women: the PROVA study. Nutr Metab Cardiovasc Dis 26:27\u201335. https:\/\/doi.org\/10.1016\/j.numecd.2015.10.007","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"822_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/HJH.0b013e328365b916","volume":"32","author":"AF Cicero","year":"2014","unstructured":"Cicero AF, Salvi P, D\u2019Addato S, Rosticci M, Borghi C (2014) Association between serum uric acid, hypertension, vascular stiffness and subclinical atherosclerosis: data from the Brisighella Heart Study. J Hypertens 32:57\u201364. https:\/\/doi.org\/10.1097\/HJH.0b013e328365b916","journal-title":"J Hypertens"},{"key":"822_CR15","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12872-016-0265-8","volume":"16","author":"JV Norvik","year":"2016","unstructured":"Norvik JV, Storhaug HM, Ytrehus K, Jenssen TG, Zykova SN, Eriksen BO, Solbu MD (2016) Overweight modifies the longitudinal association between uric acid and some components of the metabolic syndrome: The Tromso Study. BMC Cardiovasc Disord 16:85. https:\/\/doi.org\/10.1186\/s12872-016-0265-8","journal-title":"BMC Cardiovasc Disord"},{"key":"822_CR16","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1023\/A:1024600905574","volume":"18","author":"N Nakanishi","year":"2003","unstructured":"Nakanishi N, Okamoto M, Yoshida H, Matsuo Y, Suzuki K, Tatara K (2003) Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers. Eur J Epidemiol 18:523\u2013530","journal-title":"Eur J Epidemiol"},{"key":"822_CR17","doi-asserted-by":"publisher","first-page":"510","DOI":"10.3109\/0886022X.2011.653753","volume":"34","author":"V Filiopoulos","year":"2012","unstructured":"Filiopoulos V, Hadjiyannakos D, Vlassopoulos D (2012) New insights into uric acid effects on the progression and prognosis of chronic kidney disease. Ren Fail 34:510\u2013520. https:\/\/doi.org\/10.3109\/0886022x.2011.653753","journal-title":"Ren Fail"},{"key":"822_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S0002-9149(01)02155-5","volume":"89","author":"C Bickel","year":"2002","unstructured":"Bickel C, Rupprecht HJ, Blankenberg S, Rippin G, Hafner G, Daunhauer A, Hofmann KP, Meyer J (2002) Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease. Am J Cardiol 89:12\u201317","journal-title":"Am J Cardiol"},{"key":"822_CR19","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1161\/01.HYP.0000069700.62727.C5","volume":"41","author":"RJ Johnson","year":"2003","unstructured":"Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, Tuttle KR, Rodriguez-Iturbe B, Herrera-Acosta J, Mazzali M (2003) Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 41:1183\u20131190. https:\/\/doi.org\/10.1161\/01.hyp.0000069700.62727.c5","journal-title":"Hypertension"},{"key":"822_CR20","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.2174\/138161205774913255","volume":"11","author":"GK Glantzounis","year":"2005","unstructured":"Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA (2005) Uric acid and oxidative stress. Curr Pharm Des 11:4145\u20134151","journal-title":"Curr Pharm Des"},{"key":"822_CR21","doi-asserted-by":"publisher","first-page":"e0151044","DOI":"10.1371\/journal.pone.0151044","volume":"11","author":"R Kawamoto","year":"2016","unstructured":"Kawamoto R, Ninomiya D, Kasai Y, Kusunoki T, Ohtsuka N, Kumagi T, Abe M (2016) Serum uric acid is positively associated with handgrip strength among Japanese community-dwelling elderly women. PLoS One 11:e0151044. https:\/\/doi.org\/10.1371\/journal.pone.0151044","journal-title":"PLoS One"},{"key":"822_CR22","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499\u2013502","journal-title":"Clin Chem"},{"key":"822_CR23","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1053\/j.ajkd.2010.02.344","volume":"56","author":"M Horio","year":"2010","unstructured":"Horio M, Imai E, Yasuda Y, Watanabe T, Matsuo S (2010) Modification of the CKD epidemiology collaboration (CKD-EPI) equation for Japanese: accuracy and use for population estimates. Am J Kidney Dis 56:32\u201338. https:\/\/doi.org\/10.1053\/j.ajkd.2010.02.344","journal-title":"Am J Kidney Dis"},{"key":"822_CR24","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.2337\/diacare.28.9.2289","volume":"28","author":"R Kahn","year":"2005","unstructured":"Kahn R, Buse J, Ferrannini E, Stern M (2005) The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28:2289\u20132304","journal-title":"Diabetes Care"},{"key":"822_CR25","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.2337\/diacare.25.7.1252","volume":"25","author":"T Ota","year":"2002","unstructured":"Ota T, Takamura T, Hirai N, Kobayashi K (2002) Preobesity in World Health Organization classification involves the metabolic syndrome in Japanese. Diabetes Care 25:1252\u20131253","journal-title":"Diabetes Care"},{"key":"822_CR26","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1161\/STROKEAHA.108.531319","volume":"40","author":"Y Doi","year":"2009","unstructured":"Doi Y, Ninomiya T, Hata J, Yonemoto K, Arima H, Kubo M, Tanizaki Y, Iwase M, Iida M, Kiyohara Y (2009) Proposed criteria for metabolic syndrome in Japanese based on prospective evidence: the Hisayama study. Stroke 40:1187\u20131194. https:\/\/doi.org\/10.1161\/strokeaha.108.531319","journal-title":"Stroke"},{"key":"822_CR27","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.metabol.2006.05.013","volume":"55","author":"SG Tsouli","year":"2006","unstructured":"Tsouli SG, Liberopoulos EN, Mikhailidis DP, Athyros VG, Elisaf MS (2006) Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander? Metabolism 55:1293\u20131301. https:\/\/doi.org\/10.1016\/j.metabol.2006.05.013","journal-title":"Metabolism"},{"key":"822_CR28","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1093\/eurheartj\/ehi879","volume":"27","author":"C Ruggiero","year":"2006","unstructured":"Ruggiero C, Cherubini A, Ble A, Bos AJ, Maggio M, Dixit VD, Lauretani F, Bandinelli S, Senin U, Ferrucci L (2006) Uric acid and inflammatory markers. Eur Heart J 27:1174\u20131181. https:\/\/doi.org\/10.1093\/eurheartj\/ehi879","journal-title":"Eur Heart J"},{"key":"822_CR29","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s40618-016-0457-1","volume":"39","author":"MJ Hosseinzadeh-Attar","year":"2016","unstructured":"Hosseinzadeh-Attar MJ, Golpaie A, Foroughi M, Hosseinpanah F, Zahediasl S, Azizi F (2016) The relationship between visfatin and serum concentrations of C-reactive protein, interleukin 6 in patients with metabolic syndrome. J Endocrinol Invest 39:917\u2013922. https:\/\/doi.org\/10.1007\/s40618-016-0457-1","journal-title":"J Endocrinol Invest"},{"key":"822_CR30","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s12020-011-9449-2","volume":"40","author":"T Wang","year":"2011","unstructured":"Wang T, Bi Y, Xu M, Huang Y, Xu Y, Li X, Wang W, Ning G (2011) Serum uric acid associates with the incidence of type 2 diabetes in a prospective cohort of middle-aged and elderly Chinese. Endocrine 40:109\u2013116. https:\/\/doi.org\/10.1007\/s12020-011-9449-2","journal-title":"Endocrine"},{"key":"822_CR31","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3389\/fendo.2013.00052","volume":"4","author":"MA McArdle","year":"2013","unstructured":"McArdle MA, Finucane OM, Connaughton RM, McMorrow AM, Roche HM (2013) Mechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies. Front Endocrinol (Lausanne) 4:52. https:\/\/doi.org\/10.3389\/fendo.2013.00052","journal-title":"Front Endocrinol (Lausanne)"},{"key":"822_CR32","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1001\/jama.283.17.2235","volume":"283","author":"EL Kanabrocki","year":"2000","unstructured":"Kanabrocki EL, Third JL, Ryan MD, Nemchausky BA, Shirazi P, Scheving LE, McCormick JB, Hermida RC, Bremner WF, Hoppensteadt DA, Fareed J, Olwin JH (2000) Circadian relationship of serum uric acid and nitric oxide. JAMA 283:2240\u20132241","journal-title":"JAMA"},{"key":"822_CR33","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s12020-014-0239-5","volume":"48","author":"JX Zhang","year":"2015","unstructured":"Zhang JX, Zhang YP, Wu QN, Chen B (2015) Uric acid induces oxidative stress via an activation of the renin-angiotensin system in 3T3-L1 adipocytes. Endocrine 48:135\u2013142. https:\/\/doi.org\/10.1007\/s12020-014-0239-5","journal-title":"Endocrine"},{"key":"822_CR34","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s11906-006-0006-y","volume":"8","author":"DB Corry","year":"2006","unstructured":"Corry DB, Tuck ML (2006) Uric acid and the vasculature. Curr Hypertens Rep 8:116\u2013119","journal-title":"Curr Hypertens Rep"},{"key":"822_CR35","doi-asserted-by":"publisher","first-page":"F625","DOI":"10.1152\/ajprenal.00140.2005","volume":"290","author":"T Nakagawa","year":"2006","unstructured":"Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushakova O, Ouyang X, Feig DI, Block ER, Herrera-Acosta J, Patel JM, Johnson RJ (2006) A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 290:F625\u2013F631. https:\/\/doi.org\/10.1152\/ajprenal.00140.2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"822_CR36","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/ijo.2009.259","volume":"34","author":"SE Perez-Pozo","year":"2010","unstructured":"Perez-Pozo SE, Schold J, Nakagawa T, Sanchez-Lozada LG, Johnson RJ, Lillo JL (2010) Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response. Int J Obes (London) 34:454\u2013461. https:\/\/doi.org\/10.1038\/ijo.2009.259","journal-title":"Int J Obes (London)"},{"key":"822_CR37","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.2169\/internalmedicine.46.0261","volume":"46","author":"R Kawamoto","year":"2007","unstructured":"Kawamoto R, Ohtsuka N, Ninomiya D, Nakamura S (2007) Carotid atherosclerosis in normal-weight metabolic syndrome. Intern Med 46:1771\u20131777","journal-title":"Intern Med"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-017-0822-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-017-0822-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-017-0822-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T08:52:26Z","timestamp":1603875146000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-017-0822-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,19]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["822"],"URL":"https:\/\/doi.org\/10.1007\/s40618-017-0822-8","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,19]]},"assertion":[{"value":"24 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance and ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee at which the studies were conducted (IRB Approval number: 1402009).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"We obtained consent through the opt-out procedure from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}